Name: Pompe Disease Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMPH1484
Price: 4350 USD
Availability: InStock

Pompe Disease Therapeutics Market Size Share Growth Opportunities and Forecast 2022

Pompe Disease Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Pompe Disease Therapeutics Market is segmented&nbsp;By Treatment Type (Drugs, Enzyme Replacement Therapy, Physical Therapy,&nbsp;Chaperone-Advanced Replacement Therapy), By Route of Administration(Oral,&nbsp;Parenteral), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global &quot;Pompe Disease Therapeutics Market&quot;&nbsp;is expected to grow at a high <a href="https://www.datamintelligence.com/download-sample/pompe-disease-therapeutics-market">CAGR of&nbsp; 2.6%</a> during the forecasting period (2022-2029).
</blockquote>

<h2>Trending Topics</h2>

<a href="https://www.datamintelligence.com/download-sample/production-chemical-market">Production Chemical Market</a>

<a href="https://www.datamintelligence.com/download-sample/phosphorus-and-derivatives-market">Phosphorus &amp; Derivatives Market</a>

<a href="https://www.datamintelligence.com/download-sample/greenhouse-produce-market">Greenhouse Produce Market</a>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>
		&nbsp;Market Snippet by Treatment Type
		</li>
		<li>
		Market Snippet by Route of Administration
		</li>
		<li>
		Market Snippet by Region
		</li>
		<li>
		DataM CLO Scenario
		</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Launch of novel therapeutics
				</li>
				<li>
				Rise in research and development
				</li>
			</ol>
			</li>
			<li>
			Restraints

			<ol>
				<li>
				High cost of treatment
				</li>
			</ol>
			</li>
			<li>
			Opportunity
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis&nbsp;

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Epidemiology
		</li>
	</ol>
	</li>
	<li>
	Pipeline Analysis&nbsp;
	</li>
	<li>
	By Treatment Type

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Attractiveness Index, By Treatment Type
			</li>
		</ol>
		</li>
		<li>
		Drugs

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Enzyme Replacement Therapy
		</li>
		<li>
		Physical Therapy
		</li>
		<li>
		&nbsp;Chaperone-Advanced Replacement Therapy
		</li>
	</ol>
	</li>
	<li>
	By Route of Administration

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
			</li>
			<li>
			Market Attractiveness Index, By Route of Administration
			</li>
		</ol>
		</li>
		<li>
		Oral

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
			</li>
		</ol>
		</li>
		<li>
		&nbsp;Parenteral
		</li>
	</ol>
	</li>
	<li>
	By Region

	<ol>
		<li>
		Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East and Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Global Market Competitive Landscape

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor Pompe Disease Therapeutics Strategy Analysis
		</li>
		<li>
		Comparative Product Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	Company Profiles

	<ol>
		<li>
		Genzyme *

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		Amicus Therapeutics
		</li>
		<li>
		Valerion Therapeutics
		</li>
		<li>
		Audentes Therapeutics
		</li>
		<li>
		Actus Therapeutics
		</li>
		<li>
		BioMarin Pharmaceutical
		</li>
		<li>
		EpiVax
		</li>
		<li>
		Oxyrane
		</li>
		<li>
		Sangamo BioSciences
		</li>
		<li>
		Avrobio
		</li>
		<li>
		Spark Theraapeutics
		</li>
	</ol>
	</li>
	<li>
	DataM Intelligence

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables and Figures</h2>

List of Tables

Table 1&nbsp; Global Pompe Disease Therapeutics Market Value, By Treatment Type, 2021,2025 &amp; 2029 ($ Million)

Table 2&nbsp; Global Pompe Disease Therapeutics Market Value, By Route of Administration, 2021,2025 &amp; 2029 ($ Million)

Table 3&nbsp; Global Pompe Disease Therapeutics Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 4&nbsp; Global Pompe Disease Therapeutics Market Value, By Treatment Type, 2021,2025 &amp; 2029 ($ Million)

Table 5&nbsp; Global Pompe Disease Therapeutics Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 6&nbsp; Global Pompe Disease Therapeutics Market Value, By Route of Administration, 2021,2025 &amp; 2029 ($ Million)

Table 7&nbsp; Global Pompe Disease Therapeutics Market Value, By Route of Administration, 2017-2029 ($ Million)

Table 8&nbsp; Global Pompe Disease Therapeutics Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 9&nbsp; Global Pompe Disease Therapeutics Market Value, By Region, 2017-2029 ($ Million)

Table 10&nbsp; North America Pompe Disease Therapeutics Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 11&nbsp; North America Pompe Disease Therapeutics Market Value, By Route of Administration, 2017-2029 ($ Million)

Table 12&nbsp; North America Pompe Disease Therapeutics Market Value, By Country, 2017-2029 ($ Million)

Table 13&nbsp; South America Pompe Disease Therapeutics Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 14&nbsp; South America Pompe Disease Therapeutics Market Value, By Route of Administration, 2017-2029 ($ Million)

Table 15&nbsp; South America Pompe Disease Therapeutics Market Value, By Country, 2017-2029 ($ Million)

Table 16&nbsp; Europe Pompe Disease Therapeutics Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 17&nbsp; Europe Pompe Disease Therapeutics Market Value, By Route of Administration, 2017-2029 ($ Million)

Table 18&nbsp; Europe Pompe Disease Therapeutics Market Value, By Country, 2017-2029 ($ Million)

Table 19&nbsp; Asia-Pacific Pompe Disease Therapeutics Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 20&nbsp; Asia-Pacific Pompe Disease Therapeutics Market Value, By Route of Administration, 2017-2029 ($ Million)

Table 21&nbsp; Asia-Pacific Pompe Disease Therapeutics Market Value, By Country, 2017-2029 ($ Million)

Table 22&nbsp; Middle East &amp; Africa Pompe Disease Therapeutics Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 23&nbsp; Middle East &amp; Africa Pompe Disease Therapeutics Market Value, By Route of Administration, 2017-2029 ($ Million)

Table 24&nbsp; Genzyme: Overview

Table 25&nbsp; Genzyme: Product Portfolio

Table 26&nbsp; Genzyme: Key Developments

Table 27&nbsp; Amicus Therapeutics: Overview

Table 28&nbsp; Amicus Therapeutics: Product Portfolio

Table 29&nbsp; Amicus Therapeutics: Key Developments

Table 30&nbsp; Valerion Therapeutics: Overview

Table 31&nbsp; Valerion Therapeutics: Product Portfolio

Table 32&nbsp; Valerion Therapeutics: Key Developments

Table 33&nbsp; Audentes Therapeutics: Overview

Table 34&nbsp; Audentes Therapeutics: Product Portfolio

Table 35&nbsp; Audentes Therapeutics: Key Developments

Table 36&nbsp; Actus Therapeutics: Overview

Table 37&nbsp; Actus Therapeutics: Product Portfolio

Table 38&nbsp; Actus Therapeutics: Key Developments

Table 39&nbsp; BioMarin Pharmaceutical: Overview

Table 40&nbsp; BioMarin Pharmaceutical: Product Portfolio

Table 41&nbsp; BioMarin Pharmaceutical: Key Developments

Table 42&nbsp; EpiVax: Overview

Table 43&nbsp; EpiVax: Product Portfolio

Table 44&nbsp; EpiVax: Key Developments

Table 45&nbsp; Oxyrane: Overview

Table 46&nbsp; Oxyrane: Product Portfolio

Table 47&nbsp; Oxyrane: Key Developments

Table 48&nbsp; Sangamo BioSciences: Overview

Table 49&nbsp; Sangamo BioSciences: Product Portfolio

Table 50&nbsp; Sangamo BioSciences: Key Developments

Table 51&nbsp; Avrobio: Overview

Table 52&nbsp; Avrobio: Product Portfolio

Table 53&nbsp; Avrobio: Key Developments

&nbsp;

List of Figures

Figure 1&nbsp;&nbsp;Global Pompe Disease Therapeutics Market Share, By Treatment Type, 2018 &amp; 2029 (%)

Figure 2&nbsp;&nbsp;Global Pompe Disease Therapeutics Market Share, By Route of Administration, 2018 &amp; 2029 (%)

Figure 3&nbsp;&nbsp;Global Pompe Disease Therapeutics Market Share, By Region, 2018 &amp; 2029 (%)

Figure 4&nbsp;&nbsp;Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 5&nbsp;&nbsp;Global Pompe Disease Therapeutics Market Y-o-Y Growth, By Treatment Type, 2018-2029 (%)

Figure 6&nbsp;&nbsp;Drugs: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 7&nbsp;&nbsp;Enzyme Replacement Therapy: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 8&nbsp;&nbsp;Physical Therapy: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 9&nbsp;&nbsp;Chaperone-Advanced Replacement Therapy: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 10&nbsp;&nbsp;Myozyme: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 11&nbsp;&nbsp;Lumizyme: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 12&nbsp;&nbsp;Global Pompe Disease Therapeutics Market Y-o-Y Growth, By Route of Administration, 2018-2029 (%)

Figure 13&nbsp;&nbsp;Oral: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 14&nbsp;&nbsp;Parenteral: Global Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 15&nbsp;&nbsp;Global Pompe Disease Therapeutics Market Y-o-Y Growth, By Region, 2018-2029 (%)

Figure 16&nbsp;&nbsp;North America Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 17&nbsp;&nbsp;North America Pompe Disease Therapeutics Market Share, By Treatment Type, 2018 &amp; 2029 (%)

Figure 18&nbsp;&nbsp;North America Pompe Disease Therapeutics Market Share, By Route of Administration, 2018 &amp; 2029 (%)

Figure 19&nbsp;&nbsp;North America Pompe Disease Therapeutics Market Share, By Country, 2018 &amp; 2029 (%)

Figure 20&nbsp;&nbsp;South America Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 21&nbsp;&nbsp;South America Pompe Disease Therapeutics Market Share, By Treatment Type, 2018 &amp; 2029 (%)

Figure 22&nbsp;&nbsp;South America Pompe Disease Therapeutics Market Share, By Route of Administration, 2018 &amp; 2029 (%)

Figure 23&nbsp;&nbsp;South America Pompe Disease Therapeutics Market Share, By Country, 2018 &amp; 2029 (%)

Figure 24&nbsp;&nbsp;Europe Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 25&nbsp;&nbsp;Europe Pompe Disease Therapeutics Market Share, By Treatment Type, 2018 &amp; 2029 (%)

Figure 26&nbsp;&nbsp;Europe Pompe Disease Therapeutics Market Share, By Route of Administration, 2018 &amp; 2029 (%)

Figure 27&nbsp;&nbsp;Europe Pompe Disease Therapeutics Market Share, By Country, 2018 &amp; 2029 (%)

Figure 28&nbsp;&nbsp;Asia-Pacific Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 29&nbsp;&nbsp;Asia-Pacific Pompe Disease Therapeutics Market Share, By Treatment Type, 2018 &amp; 2029 (%)

Figure 30&nbsp;&nbsp;Asia-Pacific Pompe Disease Therapeutics Market Share, By Route of Administration, 2018 &amp; 2029 (%)

Figure 31&nbsp;&nbsp;Asia-Pacific Pompe Disease Therapeutics Market Share, By Country, 2018 &amp; 2029 (%)

Figure 32&nbsp;&nbsp;Middle East &amp; Africa Pompe Disease Therapeutics Market Value, 2017-2029 ($ Million)

Figure 33&nbsp;&nbsp;Middle East &amp; Africa Pompe Disease Therapeutics Market Share, By Treatment Type, 2018 &amp; 2029 (%)

Figure 34&nbsp;&nbsp;Middle East &amp; Africa Pompe Disease Therapeutics Market Share, By Route of Administration, 2018 &amp; 2029 (%)

Figure 35&nbsp;&nbsp;Genzyme: Financials

Figure 36&nbsp;&nbsp;Amicus Therapeutics: Financials

Figure 37&nbsp;&nbsp;Valerion Therapeutics: Financials

Figure 38&nbsp;&nbsp;Audentes Therapeutics: Financials

Figure 39&nbsp;&nbsp;Actus Therapeutics: Financials

Figure 40&nbsp;&nbsp;BioMarin Pharmaceutical: Financials

Figure 41&nbsp;&nbsp;EpiVax: Financials

Figure 42&nbsp;&nbsp;Oxyrane: Financials

Figure 43&nbsp;&nbsp;Sangamo BioSciences: Financials

Figure 44&nbsp;&nbsp;Avrobio: Financials